Bicycle therapeutics to present at 43rd annual j.p. morgan healthcare conference

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate at the 43rd annual j.p. morgan healthcare conference in a podium presentation on tuesday, jan. 14, at 5:15 p.m. pt, followed by a question-and-answer breakout session at 5:35 p.m. pt. a live webcast of the presentat.
BCYC Ratings Summary
BCYC Quant Ranking